Documents
Funded projects
Projects funded under this call.
ARREST
Approaching recurrence and resistance mechanisms in esophagogastric adenocarcinomas from the prospective MEMORI trial
View project
BeFIT
Patient-derived models for intratumour functional heterogeneity and its implications for personalized medicine
View project
CCE Breast
Clinical Impact of Intratumor heterogeneity in metastatic breast cancer
View project
CEVIR
Cancer evolution and identification of relapse-initiating cells.
View project
DRAMA
Defeating Recurrence and resistance in AML: Multigenomic Approaches to analyse heterogeneity
View project
FIRE-CLL
Fighting Resistance in CLL
View project
GCH-CLL
Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemia outcome and treatment resistance
View project
HetMet
Intratumour heterogeneity, clonal selection and metastatic propensity in breast cancer
View project
INTRACOLOR
Evolution of resistant clones to novel target-directed drugs in colorectal tumors. - A genetic and epigenetic study of intratumoral heterogeneity dynamics
View project
IntraMMclo
Multiple myeloma intra-clonal heterogeneity: evolution and implications of targeted therapy
View project
ITEM
Dissecting phenotypic heterogeneity of human melanoma: building a rationale for active immunotherapies overcoming immunologically-induced dedifferentiation.
View project
ONTHETRRAC
Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe
View project
PROMETOV
Proteogenomic and targeted metabolomic analysis of ovarian cancer heterogeneity and its contribution to recurrence and therapy resistance.
View project
TACTIC
TArgeting Colon Tumor Initiating Cell heterogeneity
View project
TH4RESPONS
Clinical utility of tumour heterogeneity in triple negative breast cancer and high-grade serous ovarian carcinoma for prediction of therapy response
View project
TORPEDO